Effect of chamomile versus placebo on first-degree pressure ulcer in patients hospitalized in ICU

Effect of chamomile versus placebo on first-degree pressure ulcer in patients hospitalized in ICU: a double-blind randomized clinical trial

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120215009014N205

Enrollment

Registered

2018-02-03

Start date

2018-01-21

Completion date

Unknown

Last updated

2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pressure ulcer. Pressure ulcer

Interventions

Intervention 1: Intervention group: Topical ointment including chamomile active ingredient daily for 7 days. Intervention 2: Control group: Topical ointment including placebo (Vaseline) daily for 7 da

Eligibility

Sex/Gender

All

Age

18 Years to 70 Months

Inclusion criteria

Inclusion criteria: Age of 18 to 70 years Hospitalized in ICU Having first-degree pressure ulcer

Exclusion criteria

Exclusion criteria: A history of allergy or cutaneous hypersensitivity Any hypersensitivity to chamomile

Design outcomes

Primary

Measure	Time frame
Improvement of ulcer. Timepoint: On 4 and 7 days after intervention. Method of measurement: Through physical examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Hashemi

Esfahan University of Medical Sciences

m.hashemi690@gmail.com+98 31 3668 0048

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026